Barclays’s Array Biopharma Inc ARRY Stock Holding History

Barclays’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-2,100	Closed	-$32K	–	7650
2018 Q3	$32K	Sell	2,100 -47,900	-96%	-$734K	﹤0.01%	6294
2018 Q2	$839K	Buy	+50,000	New	+$795K	﹤0.01%	3471
2018 Q1	–	Sell	-500	Closed	-$6K	–	7525
2017 Q4	$6K	Sell	500 -6,600	-93%	-$75.1K	﹤0.01%	6653
2017 Q3	$87K	Buy	+7,100	New	+$65.9K	﹤0.01%	5022

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Barclays's ARRY Position: Q3 2019 in Review

Barclays sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 586,743 shares — an estimated $27.2M sold.

Barclays first reported a position in ARRY in Q2 2013 and held it in 24 quarters. The position peaked at $27.2M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Barclays reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Barclays sold 586,743 Array Biopharma Inc shares in Q3 2019, an estimated $27.2M.
Barclays first reported a position in Array Biopharma Inc in Q2 2013 and held it in 24 quarters.
Barclays's Array Biopharma Inc position peaked at $27.2M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Barclays's 13F filing for Q3 2019, filed 14 Nov 2019.